PASQUALIN, LUCA
 Distribuzione geografica
Continente #
EU - Europa 115
AS - Asia 99
NA - Nord America 82
SA - Sud America 11
AF - Africa 2
Totale 309
Nazione #
US - Stati Uniti d'America 78
RU - Federazione Russa 54
SG - Singapore 44
IT - Italia 25
CN - Cina 17
HK - Hong Kong 17
DE - Germania 13
BR - Brasile 9
FR - Francia 5
ID - Indonesia 5
CA - Canada 4
GB - Regno Unito 4
KR - Corea 4
NL - Olanda 4
AT - Austria 2
BD - Bangladesh 2
FI - Finlandia 2
JP - Giappone 2
PL - Polonia 2
TG - Togo 2
VN - Vietnam 2
BE - Belgio 1
EC - Ecuador 1
IE - Irlanda 1
IL - Israele 1
IN - India 1
IQ - Iraq 1
LT - Lituania 1
MY - Malesia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 309
Città #
Dallas 22
Hong Kong 17
Singapore 17
Ashburn 13
Moscow 11
Verona 9
Munich 8
Los Angeles 5
Beijing 4
Kebon Manggis 3
Milan 3
Padova 3
Redondo Beach 3
Amsterdam 2
Chicago 2
Columbus 2
Helsinki 2
Jakarta 2
Lomé 2
London 2
Meda 2
Naples 2
New York 2
Nuremberg 2
Perugia 2
Rome 2
Stanford 2
The Dalles 2
Tokyo 2
Warsaw 2
Augusta 1
Baghdad 1
Barcelona 1
Barreiros 1
Bauru 1
Blumenau 1
Brejões 1
Brooklyn 1
Brussels 1
Buffalo 1
Charlotte 1
Chennai 1
Council Bluffs 1
Dhaka 1
Dublin 1
Frankfurt am Main 1
Hanoi 1
Ho Chi Minh City 1
Khulna 1
Louisville 1
Miami 1
Montreal 1
Newcastle upon Tyne 1
Orland Park 1
Phoenix 1
Pitangueiras 1
Sambir 1
Santa Clara 1
Santo André 1
Senador Firmino 1
Seoul 1
São Paulo 1
Tashkent 1
Toronto 1
Torres 1
Washington 1
Totale 188
Nome #
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 84
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 65
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 56
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 55
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 32
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 25
Totale 317
Categoria #
all - tutte 1.530
article - articoli 1.530
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 0 0 0 0 0 3 2
2023/202426 0 1 3 2 1 2 6 3 0 1 4 3
2024/2025126 12 2 11 22 8 7 5 2 18 2 13 24
2025/2026160 20 14 22 95 9 0 0 0 0 0 0 0
Totale 317